Literature DB >> 19103518

Reconstruction in the buttock region using the local fasciocutaneous infragluteal (FCI) flap.

Ch Windhofer1, W Michlits, S Gruber, Ch Papp.   

Abstract

BACKGROUND: Defects in the buttock region are frequent indications for plastic surgery and are caused by various mechanisms. Therefore, different flaps were introduced and are well established. However, all of them have their limitations in reconstruction because of their restricted arc of rotation. Hence, we indicated the use of the local fasciocutaneous infragluteal (FCI) flap for reconstruction of such defects in the buttock region.
METHODS: In a series of 14 patients, three of them being paraplegics, the authors used 15 local FCI flaps to cover defects in the buttock region. The defects were caused by pressure sores, pilonidal sinus infection with recurrence, an adenocarcinoma of the gluteal region, a massive abscess after intramuscular gluteal injection, lipodystrophy of the lateral gluteal region and by multiple operations after an infection of implanted hip-joint prosthesis.
RESULTS: The median dimension of the flaps was 177 cm(2). Fourteen of the 15 flaps healed uneventfully. In one patient, a re-mobilisation of the flap was necessary after a minor, distal-flap necrosis. Closure of the donor site was possible in all patients without further trouble. One patient needed a second local FCI flap because of a new pressure sore on the contralateral sacral region.
CONCLUSIONS: The FCI flap is not only a versatile and reliable free flap with different indications, but is also a good alternative as a local flap for defect reconstruction in the whole buttock region, as demonstrated in this study for the first time. It can be raised as a sensate flap without restrictions of mobility in ambulatory patients. The donor-site morbidity is minimal, and options for future flaps of the gluteal region are preserved. Copyright (c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 19103518     DOI: 10.1016/j.bjps.2008.08.050

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  Gluteal necrosis following pelvic fracture and bilateral internal iliac embolization: Reconstruction using a transposition flap based on the lumbar artery perforators.

Authors:  Onur Gilleard; John Stammers; Farida Ali
Journal:  Int J Surg Case Rep       Date:  2011-11-18

2.  Prospective evaluation of a single-sided innervated gluteal artery perforator flap for reconstruction for extensive and recurrent pilonidal sinus disease: functional, aesthetic, and patient-reported long-term outcomes.

Authors:  Klaus F Schrögendorfer; Werner Haslik; Oskar C Aszmann; Martin Vierhapper; Manfred Frey; David B Lumenta
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

3.  Lumbar artery perforator (LAP) flap: a salvage tool for extended lumbo-sacral necrosis after bilateral internal iliac arteries embolization.

Authors:  Pietro Giovanni di Summa; Clara Schaffer; Patrice Zaugg; Olivier Bauquis; Wassim Raffoul
Journal:  Case Reports Plast Surg Hand Surg       Date:  2016-04-18

4.  Common surgical procedures in pilonidal sinus disease: A meta-analysis, merged data analysis, and comprehensive study on recurrence.

Authors:  V K Stauffer; M M Luedi; P Kauf; M Schmid; M Diekmann; K Wieferich; B Schnüriger; D Doll
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

5.  Total Gluteal Reconstruction with "IGA-based V-Y Myocutaneous Advancement Flap".

Authors:  Madhubari Vathulya; Amborish Nath; Manish Jain; Rajkumar Kottayasamy Seenivasagam
Journal:  Indian J Plast Surg       Date:  2019-11-28

6.  Buttock Reconstruction in Sarcoma Surgery: An Esthetic Sigmoidplasty Closure for Large Circular Defects Using Double Opposing Skin Flaps.

Authors:  Corné P G Nel; Mahendra Daya
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-10-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.